期刊
JOURNAL OF DERMATOLOGICAL SCIENCE
卷 89, 期 1, 页码 27-32出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.jdermsci.2017.10.006
关键词
Atopic dermatitis; Kestose; Prebiotics; Short-chain fatty acids; Mucosal immunity
类别
资金
- Food Functionality Evaluation program under the Ministry of Agriculture, Food and Rural Affairs
- Korea Food Research Institute [G009-0100-08]
Background: Atopic dermatitis (AD) is recently increasing among populations, but the underlying mechanisms remain controversial. Interactions between the gut microbiota and mucosal immunity are considered to be a crucial etiology. Fructooligosaccharide (FOS), prebiotics have been reported as activators of the gut microbiota. Objective: The aim of this study was to investigate the effects of kestose, the smallest FOS and FOS on atopic dermatitis in mice. Methods: An AD mouse model was developed by (ovalbumin) epidermal sensitization using BALB/c mice. Kestose (1%, 5%, and 10%) or FOS (5%, positive control) was orally administered throughout the study. Results: In comparison with the values observed for the control AD mice, transepidermal water loss (TEWL), clinical score, and skin inflammation on histopathology were significantly decreased by the oral administration of kestose. Total IgE, thymic stromal lymphopoietin (TSLP) in skin, and IL-4 were also suppressed by this administration. In addition, the population of CD4(+)Foxp3(+) cells in mesenteric lymph nodes (MLNs) and acetate concentrations in feces were significantly increased by kestose treatment. Conclusions: These findings suggest that kestose activates the gut immune system to induce the tolerance against allergic skin inflammations in AD. (C) 2017 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据